DarioHealth Corp. (DRIO) intrinsic value & 10-year financials
DarioHealth Corp. (DRIO) has a Graham intrinsic value of $336.14 per share. At $4.82 on Oct 17, 2026, the stock trades 99% below that value. Over the last 10 fiscal years revenue grew 25.9% a year to $22.4M, with an average return on invested capital of 738.3%.
- Graham intrinsic value
- $336.14
- Share price (Oct 17, 2026)
- $4.82
- Price vs Graham value
- 99% below
- Market cap
- $19.2M
- Revenue (FY2025)
- $22.4M
- Revenue growth (10-yr CAGR)
- 25.9%
- ROIC (10-yr avg)
- 738.3%
- Free cash flow (FY2025)
- -$26.1M
DRIO 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $22.4M | -$41.7M | $10.12 | -$26.1M | -163.9% | -48.4% |
| FY2024 | $27.0M | -$42.7M | $0.61 | -$38.7M | -213.6% | -88.8% |
| FY2023 | $20.4M | -$59.4M | $1.93 | -$31.0M | -276.1% | -102.9% |
| FY2022 | $27.7M | -$62.2M | $2.54 | -$48.3M | -205.4% | -105.0% |
| FY2021 | $20.5M | -$76.8M | $4.07 | -$50.7M | -372.9% | -308.8% |
| FY2020 | $7.6M | -$29.4M | $4.01 | -$17.9M | -394.7% | 4662.7% |
| FY2019 | $7.6M | -$17.7M | — | -$15.8M | -234.2% | 1137.7% |
| FY2018 | $7.4M | -$17.8M | — | -$11.5M | -239.2% | 859.2% |
| FY2017 | $5.2M | -$15.7M | — | -$10.8M | -278.9% | 1211.0% |
| FY2016 | $2.8M | -$10.9M | — | -$9.2M | -396.0% | 166.4% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
DarioHealth Corp. is a consistent compounder, expanding top-line revenue at 26.0% annually over the past decade.
DarioHealth Corp. has historically struggled to out-earn its cost of capital, averaging just -26.8% ROIC.
DarioHealth Corp. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, DarioHealth Corp. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $336.14 per share.